16. Novel Therapies

Experience novel therapies in IBD, and of clinical trials used to pilot their introduction


Full content only available after log-in


16.1.  Understands the different types of evidence – clinical trial / cohort study / systematic review etc.

16.2.  Knows the evidence that supports the use of currently unlicensed therapies in IBD


        
 
Topic:


Programme Phase:



Content Format:








Page: 1 2 3 4 5 ()

Topic 16 : Educational update

Tandem talk : IBD therapeutics targets and drugs: New and old

J Lindsay, Y Chowers

11th IBD Intensive Advanced Course

Webcast
 


Topic 16 : Educational update

Faecal transplantation for UC?

G Van den Brink

ECCO 2015 Barcelona Congress

Webcast
 


Topic 16 : Educational update

Stem-cell transplantation: Hope or expectation?

E Ricart

ECCO 2015 Barcelona Congress

Webcast
 


Topic 16 : Educational update

Medical therapies around the corner

G Van Assche

ECCO 2015 Barcelona Congress

Webcast
 


Topic 16 : Educational update

Clinical trial terminology & processes. Standard investigations

V Jairath

ECCO 2016 Amsterdam Congress

Webcast
 


Topic 16 : Educational update

How to optimise recruitment to clinical trials in IBD

A Hart

ECCO 2016 Amsterdam Congress

Webcast
 


Topic 16 : Educational update

Tips & tricks for the IBD clinical research team

J Lefrère, G Schops

ECCO 2016 Amsterdam Congress

Webcast
 


Topic 16 : Educational update

What does the future hold for IBD clinical trials?

W Reinisch

ECCO 2016 Amsterdam Congress

Webcast
 


Topic 16 : Educational update

New treatments targeting the microbiota (FMT, antibiotics) – a case-based discussion

J Kierkuś

ECCO 2017 Barcelona Congress

Webcast + PPT
 


Topic 16.1 : State of the art

Trial endpoint vs. therapeutic objectives

F Baert

ECCO 2017 Barcelona Congress

Webcast + PPT
 


Page: 1 2 3 4 5 ()